Chronos Therapeutics
Oxford based Biotech seeking partners to take forward our NCE assets in behavioural brain disease to complete IND enabling and move into clinic. We are open to licensing and funding/collaboration discussions. Orexin 1 antagonist in Addiction. Atypical DAT inhibitor in Fatigue (with potential in Narcolepsy).
